Pharmaceutical company Darnytsia has submitted a complaint to the Antimonopoly Committee of Ukraine (AMCU) regarding possible anticompetitive actions by five of the country’s largest pharmacy chains and two distributors. The complaint, submitted on [insert date], alleges that these entities have engaged in practices that may restrict competition and unfairly advantage their positions in the market.
The AMCU is responsible for enforcing Ukraine’s antitrust laws, which aim to ensure fair competition and protect consumers from monopolistic practices. Darnytsia’s filing suggests that the company believes its business has been adversely affected by these actions, potentially leading to higher drug prices or reduced access to essential medications.
Industry experts have noted that such antitrust cases are common in markets with a high concentration of players, and the outcome could set a precedent for how such issues are handled in Ukraine. The AMCU is expected to investigate the claims and determine whether any violations have occurred, which could result in regulatory action against the accused entities.